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ABSTRACT: Luminescent, mixed metal d−f complexes have the potential to be used for dual
(magnetic resonance imaging (MRI) and luminescence) in vivo imaging. Here, we present
dinuclear and trinuclear d−f complexes, comprising a rigid framework linking a luminescent Ir
center to one (Ir·Ln) or two (Ir·Ln2) lanthanide metal centers (where Ln = Eu(III) and
Gd(III), respectively). A range of physical, spectroscopic, and imaging-based properties
including relaxivity arising from the Gd(III) units and the occurrence of Ir(III) → Eu(III)
photoinduced energy-transfer are presented. The rigidity imposed by the ligand facilitates high
relaxivities for the Gd(III) complexes, while the luminescence from the Ir(III) and Eu(III) centers provide luminescence imaging
capabilities. Dinuclear (Ir·Ln) complexes performed best in cellular studies, exhibiting good solubility in aqueous solutions, low
toxicity after 4 and 18 h, respectively, and punctate lysosomal staining. We also demonstrate the ﬁrst example of oxygen sensing
in ﬁxed cells using the dyad Ir·Gd, via two-photon phosphorescence lifetime imaging (PLIM).
■ INTRODUCTION
The use of transition-metal luminophores to sensitize
luminescence from lanthanide(III) ions in mixed d−f
complexes has attracted recent attention from many
researchers.1 The long-lived excited states of many d-block
luminophores with triplet excited states make them excellent
energy donors whose excited-state energy can be tuned over a
wide range by control of ligand type and substituents; in
addition, numerous straightforward synthetic methods exist to
combine d-block and f-block units such that d−f energy-
transfer can occur with the d-block unit acting as the light-
harvesting antenna for the lanthanide ion, for which direct f−f
excitation is Laporte-forbidden.1 Among such d−f hybrids the
extensive family of cyclometalated phenyl-pyridine/Ir(III)
complexes, with their high energy and long-lived triplet excited
states that result in blue or green luminescence,2 have proven to
be eﬀective energy-donors for generating luminescence from
lanthanides such as Eu(III), Tb(III), Yb(III), and Nd(III) in Ir/
Ln dyads.3,4 The ﬁrst example came from De Cola and co-
workers, who demonstrated that the combination of blue
Ir(III)-based emission and red Eu(III)-based emission from a
single molecular ediﬁce could be used to generate white light,4a
and many other examples have been reported since then.
In addition, the use of luminescent transition-metal and
lanthanide complexes with long-lived excited states has become
very popular in bioimaging applications over the past decade.5,6
This, combined with technological developments in electronic
shutters and optics, has resulted in time-resolved imaging
techniques becoming more commonplace in the biosciences.
These techniques include the simple rejection of short-lived
background autoﬂuorescence via time gating, and “lifetime
mapping” using a combination of single photon counting and
scanning confocal microcopy, as demonstrated by phosphor-
escence lifetime imaging (PLIM) and time-resolved emission-
imaging microscopy (TREM).7
One area that has beneﬁted from these developments is the
real-time detection and quantiﬁcation of oxygen via phosphor-
escence quenching.7a,c−f,8 Molecular oxygen has a triplet
ground-state conﬁguration and is an eﬀective quencher of the
triplet-based phosphorescence displayed by transition-metal
complexes. Molecular oxygen also plays a key role in many
physiological processes, ATP generation, and mitochondrial
function.9d−f Low or inadequate levels of oxygen, referred to as
hypoxia, are important features in solid tumors, inﬂammatory
diseases, and Alzheimer’s disease.9a−c,g Hence, the ability to
monitor oxygen concentration in vivo and in vitro, under real-
time noninvasive conditions, is extremely desirable for
diagnostics and treatment. Optical oxygen monitoring and
imaging using lifetime-based techniques have advantages over
intensity-based ones. Decay of photoexcited molecules typically
follows ﬁrst-order decay kinetics, so lifetime measurements are
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not aﬀected by the intensity of the excitation light, and lifetime
measurements are a property of the individual molecule, and
are therefore, largely concentration-independent. Measuring the
emission lifetime of a probe, rather than the emission intensity,
provides a quantitative, noninvasive method by which
intercellular oxygen concentrations can be monitored. Inten-
sity-based measurements can be used for quantitative oxygen
sensing with ratiometric probes, where the emissive molecule is
both the probe and the internal calibrant. Recent examples of
oxygen detection using luminescent transition-metal complexes
have involved Pt(II) complexes,7a,8c−e,10 Pd(II) porphyrins,8b,11
Ru(II)12 and Ir(III)8a,13 complexes, including iridium-based
upconverting nanoparticles doped with lanthanides.13b
As part of a study to investigate the use of d/f hybrid
complexes as cellular imaging probes, we recently reported the
preparation and study of complexes Ir·Eu and Ir·Gd (Figure 1),
in which a strongly luminescent [Ir(F2ppy)2(phen)]
+ unit is
connected to a stable lanthanide(III) polyamino-carboxylate
chelate via a fully conjugated alkyne bridge.14 The design of
these complexes has three particularly beneﬁcial features. First,
the conjugated pathway connecting the two metal centers
allows eﬃcient Ir(III) → Eu(III) energy transfer by the Dexter
mechanism, which requires electronic coupling between donor
and acceptor.1c,15 Thus, excitation of the Ir(III) unit under
either single-photon or two-photon conditions was followed by
partial Ir(III) → Eu(III) energy transfer to give a mixture of
green Ir(III)-based emission (microsecond time scale) and red
Eu(III)-based emission (millisecond time scale). Second, the
extended conjugated bridge, which is involved in metal-to-
ligand charge transfer (MLCT) transitions, may aﬀord a
signiﬁcant two-photon absorption cross section, which will
assist with imaging under two-photon excitation conditions.
Third, the rigidity imparted to the complex by the rigid rodlike
structure resulted in a high relaxivity for the mononuclear
Gd(III) center associated with slow tumbling in solution,16 and
we note that d/f complexes combining a luminescent unit and a
Gd(III) unit for dual-mode luminescence imaging/magnetic
resonance imaging (MRI) have attracted particular interest
recently.17 Generally, for MRI-based applications, the required
high relaxivity for protons of water molecules arises from a
combination of factors, such as the number of sites available for
water to coordinate to the Gd(III) center and their exchange
rate (inner-sphere relaxivity), interactions between the Gd(III)
center and more-remote water molecules (outer-sphere
relaxivity), the rotational correlation time of the molecules in
solution, and the longitudinal and transverse electron spin
relaxation times of Gd(III), as encapsulated in Solomon−
Bloembergen−Morgan theory.18
In this follow-up paper, we report on two related areas. First,
we have substantially extended the scope of the cellular imaging
studies performed with Ir·Eu and Ir·Gd, demonstrating in
particular how we can use the lifetime of the Ir(III)-based
luminescence as a probe for the oxygen concentration in cells
under in vitro conditions. Second, we report the new trinuclear
complexes Ir·Eu2 and Ir·Gd2 (Figure 1) in which two Ln(III)
units are pendant from the central [Ir(F2ppy)2(phen)]
+ and
describe their photophysical properties and use in imaging
studies.
■ RESULTS AND DISCUSSION
Synthesis of New Trinuclear Complexes. Synthesis of
the trinuclear Ir·Ln2 complexes follows the same general
methodology as used for the dinuclear Ir·Ln complexes that
were reported earlier (Scheme 1).14 The ester-protected
pyridine-2,6-bis(imino-diacetate) unit, which ends up as the
Ln(III) binding site, contains a central pyridyl group, which can
be functionalized with a Br atom at the C4 position (precursor
A). This permits its connection to the [Ir(F2ppy)2(phen)]
+
sensitizer via alkynyl linkages introduced in a Sonogashira
coupling reaction. Whereas the use of 3-ethynyl-1,10-
phenanthroline aﬀorded the dinuclear Ir·Ln complexes using
this methodology,14 in this new work use of 3,8-di(ethynyl)-
1,10-phenanthroline (precursor B) allowed connection of the
Br-functionalized bis(imino-diacetate) unit to both alkynyl sites
to give compound C. After assembling the component binding
sites in this way, coordination of the phenanthroline unit of C
to an {Ir(F2ppy)2}
+ unit, and unmasking of the amino/
carboxylate binding site by removal of the esters, followed by
incorporation of Eu(III) or Gd(III), all used standard methods.
Incorporation of the pyridyl group into the lanthanide binding
sitein contrast to use of the cyclen-tricarboxylate chelate that
we used in our earlier work3fallows the Sonogashira coupling
to provide a fully conjugated pathway between the Ir(III) and
lanthanide (Ln) centers.
Accordingly, these trinuclear complexes Ir·Ln2 should be
expected to have all of the same beneﬁts arising from their
structure as do the dinuclear ones, viz, eﬃcient Ir(III) →
Eu(III) energy transfer; a two-photon absorption cross section
suﬃcient for imaging purposes; and structural rigidity to impart
high relaxivity to the Gd(III) units.
Steady-State and Time-Resolved Luminescence Prop-
erties of the Trinuclear Complexes. UV-vis absorption
spectral data of the complexes in water are summarized in
Table 1. Intense absorptions in the UV region are due to
Figure 1. Structures of the dinuclear and trinuclear complexes
discussed in this paper, and a mononuclear Ir(III) complex Ir·L1 used
in the DFT calculations.
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.6b00702
Inorg. Chem. XXXX, XXX, XXX−XXX
B
ligand-centered π → π* electronic transitions; the weak
shoulder and long tail between 400 and 550 nm are ascribed
to Ir(III) → phen 3MLCT transitions (see Figure S13 in the
Supporting Information). It was observed that there is an ∼10−
15 nm bathochromic (red) shift, as well as an increase in
intensity, of the absorption bands in the case of Ir·Ln2,
compared to the Ir·Ln complexes, which we ascribe to (i) the
greater extent of the conjugated network on the substituted
phenanthroline ligand in the latter case, and (ii) the presence of
two Ln(III) units and their associated aromatic ligands instead
of just one.
Luminescence spectra (see Figure 2) of Ir·Ln and Ir·Ln2
were recorded in aerated aqueous solution upon excitation at
400 nm. In Ir·Gd2, the Ir(III)-based luminescence maximum is
observed at 595 nm: this is signiﬁcantly red-shifted, compared
to Ir·Gd (560 nm), which is a consequence of the more-
extended π-network around the phen ligand involved in the
MLCT transition, which will stabilize its lowest unoccupied
molecular orbital (LUMO). At 77 K (1:4 MeOH/EtOH frozen
glass), the rigidochromism expected from a charge-transfer
state is clear (see Figure 3), with the highest-energy emission
feature now occurring at 529 nm, indicating a 3MLCT energy
of 18 900 cm−1 (compared to 20 200 cm−1 for Ir·Gd).
Signiﬁcantly, this energy value for the Ir(III) → phen
3MLCT state is now marginal for eﬃcient sensitization of the
emissive 5D0 level of Eu(III), which lies at 17 500 cm
−1
 the
Scheme 1. Procedure for the Synthesis of the Trinuclear Ir·
Ln2 Complexes
Table 1. UV-vis Absorption and Luminescence Spectral Data for the Complexesa
compound λmax [nm] (ε [× 10
−3 M−1 cm−1]) λem [nm] τ1
0, τ2
0 [ns]b τ1, τ2 [ns]
b ϕc ref
Ir·Gd 242 (46), 285 (42), 338 (22) 560 1100, 450 640, 220 0.048 ref 14
Ir·Eu 242 (50), 283 (44), 343 (23) 578, 590, 615, 684, 697d 780, 116 510, 95 ref 14
D 241 (81), 285 (79), 355 (52) 552 1470, 275 this work
E 241 (93), 290 (96), 356 (73) 590 890, 150 this work
Ir·Gd2 242 (112), 292 (119), 358 (104) 595 1260, 233 0.026 this work
Ir·Eu2 241 (118), 292 (127), 357 (111) 616
b 1240, 168 this work
aAll measurements were carried out in air-equilibrated water at room temperature. The excitation wavelength for luminescence studies was 400 nm
in every case. bIr(III)-based luminescence lifetimes: all complexes showed dual-exponential luminescence decay (see main text). τ = air-equilibrated
solution. τ0 = argon-equilibrated solution. cQuantum yield values in aerated solvent recorded in DMSO against 1,3-di(2-pyridyl)benzene
platinum(II) chloride in CH2Cl2 as a reference (φ = 0.039; see ref 20)
dEu(III)-based emission maxima, which partly obscure the Ir(III)-based
emission; see main text.
Figure 2. Luminescence spectra of the complexes (10−5 M in water).
λex = 400 nm in each case. Insets show the visual appearance under a
UV lamp.
Figure 3. (Left) Luminescence spectra in MeOH/EtOH (1:4) of Ir·
Gd2, in ﬂuid solution at RT (black) and as a frozen glass at 77 K (red).
(Right) Luminescence spectra in MeOH/EtOH (1:4) of Ir·Eu2 in
ﬂuid solution at RT (pink) and as a frozen glass at 77 K (green). λex =
400 nm for all cases.
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gradient for energy transfer is only 1400 cm−1  so, on this
basis, we might not see eﬃcient sensitization of Eu(III)-based
luminescence in Ir·Eu2, as a gradient of ca. 2000 cm
−1 for
energy transfer at room temperature (RT) is normally
considered necessary to prevent thermally activated back-
energy transfer.3e,19 Quantum yield values of dyad Ir·Gd (Φ =
0.048) and triad Ir·Gd2 (Φ = 0.026) were measured in
dimethyl sulfoxide (DMSO), showing that the lower-energy
luminescence of Ir·Gd2 is also slightly lower in intensity.
Comparison of the luminescence spectra of dyad Ir·Eu and
triad Ir·Eu2 demonstrate nicely the diﬀering ability of their
Ir(III)-centered 3MLCT states to sensitize Eu(III) emission
(Figure 2). The luminescence spectrum of Ir·Eu in water
(reported previously14) shows how signiﬁcant Ir(III)→ Eu(III)
EnT (energy transfer) has occurred, with the Ir(III)-based
luminescence reduced in intensity, compared to what was
observed for Ir·Gd and the characteristic sharp emission lines
from Eu(III) superimposed on the low-energy tail of the broad
Ir(III)-based luminescence. In contrast, in the luminescence
spectrum of Ir·Eu2 (Figure 2, green trace) the sharp Eu(III)-
based emission lines are barely visible. They are clearly present
to some extent as they distort the envelope of the Ir(III)-based
luminescence: a small just-visible feature at 615 nm may be
ascribed to the tip of the most intense Eu(III)-emission
component, but the sensitized Eu(III)-based luminescence is
clearly very much weaker in Ir·Eu2 than in Ir·Eu. Quantum
yield determinations for dyad Ir·Eu and triad Ir·Eu2 were not
performed, because of substantial overlap of the Ir(III)-based
Eu(III)-based emission components; and, in any case, a single
quantum yield value encapsulating the combined emission from
two quite diﬀerent luminophores is not a useful parameter.
The diﬀerences in Ir(III) → Eu(III) EnT between Ir·Eu and
Ir·Eu2 are also apparent from time-resolved measurements. Ir·
Eu showed substantial quenching of the Ir(III)-based emission
lifetime compared to Ir·Gd, associated with an Ir(III) →
Eu(III) EnT rate of ca. 6 × 106 s−1,14 there is much less
diﬀerence between the unquenched Ir(III)-based emission
lifetimes of Ir·Gd2 (τ = 1260 and 230 ns) and Ir·Eu2 (τ = 1240
and 168 ns). Based on the shorter-lived emission component,
we can estimate an Ir(III) → Eu(III) EnT rate of ca. 1.6 × 106
s−1 in Ir·Eu2: this comes from eq 1, in which τu is the
“unquenched” lifetime (i.e., in the Ir/Gd complex) and τq is the
“quenched” lifetime (i.e., in the Ir/Eu complex).
τ τ
= −k
1 1
EnT
q u (1)
The energy-transfer rate constant for Ir·Eu2 is clearly
considerably smaller than that for Ir·Eu, because of the smaller
thermodynamic gradient, and this is also in agreement with the
appearance of the steady-state spectra.
Theoretical Calculations. Quantum mechanical calcula-
tions were carried out in an eﬀort to understand the optical
properties and charge transfer behavior of the two major
Ir(III)-containing rigid skeletons. Calculations were performed
on mononuclear Ir(III) complexes Ir·L1 (Figure 1) and E
(Scheme 1), i.e., the fully functionalized and deprotected Ir(III)
complexes, with the pendant pyridyl/amine/acid binding sites
but without the attached Ln(III) ions. All calculations were
performed using the Gaussian 09 program suite21 with Becke’s
three-parameter hybrid exchange functional (B3LYP);22 a basis
set of 6-31G* was employed for H, C, N, and O atoms and, for
Ir(III), we used the LanL2DZ23 basis set. The calculations
revealed that the conjugated phenanthroline-based ligands with
alkyne substituents in both Ir·L1 and E are planar. Moreover,
there is a prominent (0.149 eV) reduction of energy gap (ΔE)
between the highest occupied molecular orbital (HOMO) and
LUMO upon moving from Ir·L1 (ΔE = 2.630 eV) to E (ΔE =
2.481 eV; cf. Figures S24 and S25, respectively, in the
Supporting Information), which is attributed to the stabilization
of the LUMO that results from an eﬀective expansion of the π-
electron cloud throughout the rigid rod ligand, with the second
alkynyl/pyridine substituent. This ﬁnding is fully in agreement
with the observed red shift of the absorption bands in E, which
are in the UV region, characteristic of the π → π* electronic
transition (see Figure S13).
The systems were then carefully analyzed in accord with a
number of molecular orbital digrams from HOMO−20 to
LUMO+20 to explain other electronic features. In the case of
Ir·L1, HOMO−2 is mainly concentrated on Ir(III)-based
antenna group and the LUMO is located throughout the
conjugated fragments (Figure S24). On this basis, we assign the
3MLCT band, observed in the visible region for Ir·L1, to be due
to the HOMO−2 → LUMO electronic transition (see Figure
S26 in the Supporting Information). In the case of the larger
complex E, HOMO−4 and HOMO−16 have substantial
Ir(III)-based character and the LUMO is centered mainly on
the extended phen/alkyene ligand, extending to include the
pyridyl rings (Figure S25). Thus, the 3MLCT transition could
be assigned due to the HOMO−4 → LUMO and HOMO−16
→ LUMO electronic transitions (Figure S27 in the Supporting
Information).
Time-dependent density functional theory (TD-DFT)
(B3LYP/6-31G*) simulations of the electronic spectra of Ir·
L1 and E were also performed. The TD-DFT stick spectra
obtained from this analysis are in good agreement with the
experimental spectra (cf. Figure S26 and S27, and Tables S2−
S4 in the Supporting Information). In fact, the 3MLCT-based
transitions involving the Ir(III)-dominated MOs are seen to
give rise to very weak bands observed in the visible region of
the experimentally determined steady-state absorption spectra
(cf. Tables S2 and S3).
Relaxivity of Ir·Gd and Ir·Gd2. We reported previously
that dinuclear Ir·Gd has a relaxivity of 11.9 mM−1 s−1 in
aqueous solution at 37 °C and 20 MHz, which is a value that is
considerably higher than that normally observed for mono-
nuclear Gd(III) chelates of this type, which was ascribed to the
rigidity of the rod-shaped complex.14 Trinuclear Ir·Gd2 is not
suﬃciently soluble for relaxivity measurements in pure water as
solubilities of the order of millimolar (mM) are required.
Instead, the relaxivity of Ir·Gd2 was measured in a DMSO/
water (5:95, v/v) mixture, and the relaxivity of Ir·Gd was
remeasured under the same conditions for comparison, because
the presence of DMSO increases solvent viscosity. Note that
the relaxivity values for the analogous compounds Ir·Eu and Ir·
Eu2 were not measured, since the nonsymmetrical electron
conﬁguration of Eu(III) is well-known to result in a spin
relaxation time that is too short to alter the relaxivity of
protons.24
Complex Ir·Gd, in this solvent mixture, has a relaxivity
slightly higher than in aqueous solution (14.0 mM−1 s−1, cf.
11.9 mM−1 s−1 in water, both at 20 MHz, 37 °C). The relaxivity
of Ir·Gd2 is slightly lower than that of Ir·Gd (12.6 mM
−1 s−1) at
this frequency, despite the presence of a second Gd(III) center.
The relaxivity values of these species are comparable to those of
complexes with very similar Gd(III) coordination environments
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.6b00702
Inorg. Chem. XXXX, XXX, XXX−XXX
D
in aqueous solution,25 but signiﬁcantly higher (in the case of Ir·
Gd) than those observed with diethylenetriamine-pentaacetic
acid (DTPA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid (DOTA)-like molecules, which are typically
4−5 mM−1 s−1. This is mostly due to the rigidity of the local
ligand framework about the metal center, leading to fast water
exchange rates.25a The lower relaxivity of Ir·Gd2 than Ir·Gd at
20 MHz may arise from the complex relationship between
rotational correlation time, relaxivity, and measurement
frequency:26 but also, in part, it may arise from the poor
solubility of Ir·Gd2, which would cause aggregation of the
complex and change the eﬀective hydration state of the Gd(III)
center.
Imaging Studies Using Ir·Eu and Ir·Gd. During the initial
imaging studies with dyads Ir·Eu and Ir·Gd, we observed that
Ir·Gd was taken up by MCF7 cells considerably more
eﬀectively than Ir·Eu,14 which was a surprise, given their
structural similarity: this might be related to a change in
coordination number between Eu(III) and Gd(III). Two-
photon PLIM measurements conﬁrmed that the diﬀerences in
Ir(III)-based emission lifetimes, arising from partial quenching
by Ir(III) → Eu(III) EnT in Ir·Eu, but not in Ir·Gd, could also
be detected in cells.
Here, we report additional imaging studies using these
complexes in HeLa cells. As with MCF7 cells, we noticed that
cellular uptake of the two dyads was markedly diﬀerent. The
luminescence intensity observed after 18 h of incubation with
Ir·Gd was much higher than that observed with Ir·Eu, implying
a more eﬃcient uptake of Ir·Gd. This is apparent in the
distance versus luminescence intensity line proﬁles for the two
complexes, following incubation at 100 μM (Figure 4): across
individual cells, Ir·Gd displays intensity values that are
approximately double that of Ir·Eu, with the brightest pixels
for the punctate emission showing almost triple the
luminescence intensity that was obtained with Ir·Eu. If there
were no diﬀerence in uptake between the two complexes, we
would expect to see only a ca. 20% enhancement in emission
intensity from Ir·Eu to Ir·Gd (based on the diﬀerences in
Ir(III)-based emission intensity between the two complexes
arising from partial quenching in Ir·Eu). We tentatively
attribute this to diﬀerence in cellular uptake with a subtle
diﬀerence in the coordination sphere around the lanthanide
ion, as other attributes of the dyads, overall size, charge and
lipophilicity are virtually the same. Figure S15 in the Supporting
Information shows the comparative uptake of Ir·Eu and Ir·Gd
in HeLa cells across a range of concentrations (100−25 μM),
with images being recorded using the same instrument
parameters (initially optimized for Ir·Eu at 100 μM) to allow
direct comparison. Optimizing imaging parameters per sample
(Figure S16 in the Supporting Information) allowed the
staining pattern of the dyads in HeLa cells to be clearly
observed. The staining of Ir·Eu and Ir·Gd in HeLa cells is very
similar to that observed in MCF7 cells, in that emission from
the dyads is observed in the cell cytosol with some additional
punctate staining. The complexes were not observed to cross
the nuclear membrane.
Co-localization studies with lysotracker Red (Figure 5) show
a very good correlation with the punctate staining observed for
the dyads. Qualitative overlay images (Figure 5, right panel,
gray scale), generated using the co-localization threshold in
ImageJ, show a good correlation between the punctate Ir(III)-
based emission (green) and lysotracker emission (red). Control
images (lysotracker only, Figure S17 in the Supporting
Information) conﬁrm that there is no crosstalk of lysotracker
emission under 405 nm excitation.
The degree of co-localization between lysotracker and the Ir·
Ln complexes is reﬂected in the Manders coeﬃcients27
(obtained using Coloc2 plugin, ImageJ): These are values
between 0 and 1, which measure the extent of co-occurrence
between red and green pixels (where 0 is no co-occurrence and
1 is perfect co-occurrence). The coeﬃcient M1 takes into
account the red channel ﬁrst, asking the question, “if there is a
red pixel, is there also a co-localized green one?” The coeﬃcient
M2 is calculated using the green channel ﬁrst (i.e., “if there is a
green pixel, is there also a colocalized red one?”).
The M1/M2 values for lysotracker with either Ir·Eu or Ir·Gd
are similar at 0.99/0.73 (lysotracker + Ir·Eu) and 0.91/0.87
(lysotracker + Ir·Gd). The fact that M1 is close to 1 and M2 is
not 0 in both cases indicates that (i) there is a good co-
localization between lysotracker and Ir·Ln, and (ii) the Ir·Ln
complexes do not exclusively stain the lysosome, which
supports what we see in the steady-state confocal images.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) toxicity assays show a decrease of ca. 20% in cell
survival, particularly at higher incubation concentrations (100
μM) and incubation times (up to 18 h), associated with uptake
of the complexes into the cells. However, the reduction in cell
viability with the Ir·Ln complexes is much less signiﬁcant with
an incubation time of only 4 h: under these conditions, cell
survival fractions here are similar to the control experiments.
Overall, the dinuclear Ir·Ln complexes appear to be only
slightly toxic to HeLa cells, even at high concentrations and
long incubation times, and under conditions used for imaging
and oxygen sensing (see below), these dinuclear complexes do
not appear to have any signiﬁcant eﬀect on cell viability.
Imaging Studies Using Ir·Eu2 and Ir·Gd2. The trinuclear
complexes Ir·Eu2 and Ir·Gd2 display a very similar staining
pattern in HeLa cells to that of the dinuclear complexes (Figure
6). However, their uptake into HeLa cells was observed to be
generally poorer than Ir·Ln complexes. As size and charge have
transpired to be two key factors in cellular uptake of metal-
based imaging agents, where small cationic complexes have a
Figure 4. (Top) Comparison of confocal microscopy images taken
from HeLa cells treated with Ir·Gd and Ir·Eu at 100 μM (scale bar =
20 μm). (Bottom) Intensity versus distance plots for Ir·Gd (blue) and
Ir·Eu (green) showing diﬀerence in cellular luminescence intensities
along the lines shown in the top images. Imaging parameters,
optimized for Ir·Eu at 100 μM, remained constant for direct
comparison. λex = 405 nm. λem = 500−530 nm.
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.6b00702
Inorg. Chem. XXXX, XXX, XXX−XXX
E
tendency to perform the best,28 it is therefore logical that the
larger, anionic triads (Ir·Ln2) are less eﬃciently taken up into
mammalian cells than the smaller, neutral dyads (Ir·Ln). The
uptake trend between the two triad complexes appeared to
exhibit behavior opposite to that of the dinuclear complexes, in
that Ir·Eu2 was taken up more eﬀectively than Ir·Gd2. Again,
such a diﬀerence is unexpected, given the structural similarity of
the triads, and may arise from a change in coordination number
between Eu(III) and Gd(III). However, the mediocre solubility
of the triads in aqueous solution, when diluted from a DMSO
stock, means that this diﬀerence between uptake of Ir·Eu2 and
Ir·Gd2 may actually be related to solubility. Confocal images of
HeLa cells stained with Ir·Ln2 (Figure 6, left and middle),
obtained using an identical set of parameters (initially
optimized for Ir·Eu2 at 100 μM) depict the strong diﬀerence
between uptake of Ir·Eu2 and Ir·Gd2: the emission intensity
arising from the cells stained with Ir·Eu2 is clearly the brighter
of the two, despite the inherently weaker emission of the Ir unit
[arising from slight quenching by the Eu(III) ions].
Poor cellular uptake of the trinuclear complexes is reﬂected
in the MTT toxicity data (see Figure S19 in the Supporting
Information). The survival fractions of HeLa cells after
incubation with 100 μM of either of the trinuclear complexes
for 18 h are very similar to those obtained for 0.5% DMSO and
1% DMSO control experiments, implying that uptake into the
cells is poor. The relatively poor solubility of the Ir·Ln2
trinuclear complexes (in comparison to the dinuclear Ir·Ln
analogues) may contribute to this. Nonetheless, luminescence
spectra recorded directly from live HeLa cells (Figure 7) do
show that the complexes remain intact during transport across
the cell membrane (compare the spectra in Figure 7 with the
spectra shown in Figure 2).
O2 Sensing Using Ir·Gd. The Ir·Gd dyad is an ideal
candidate for further investigations in time-resolved imaging
applications, for many reasons:
(i) it is highly soluble in aqueous solution;
(ii) it can be taken up eﬃciently into both MCF7 and HeLa
cells;
(iii) it exhibits low toxicity;
(iv) it shows appreciable excitation under two-photon
excitation; and
(v) it has a luminescence lifetime on the order of hundreds
of nanoseconds, which makes lifetime variations easy to
measure.
Therefore, we wished to evaluate its suitability for lumines-
cence-based O2 sensing in cells. To do this, we investigated the
emission lifetime of Ir·Gd under increasing concentrations of
O2 (using O2:N2 mixtures) in aqueous solution, in full cell
Figure 5. Co-staining of HeLa cells with Ir·Ln and lysotracker Red. (Top) Ir·Eu and (bottom) Ir·Gd. Live HeLa cells were incubated with Ir·Eu at
100 μM and Ir·Gd at 50 μM in full media for 18 h before the addition of lysotracker Red. Live cells were washed with PBS and imaged in full
(phenol-red free) media. (Left) Ir·Ln, with λex: 405 nm, λem = 500−550 nm; (middle) lysotracker Red, with λex = 561 nm, λem = 590−700 nm;
(right) overlay, with co-localization depicted by gray. (Scale bar = 10 μm throughout.)
Figure 6. (Left) Comparison of Ir·Eu2 uptake in live HeLa cells and (middle) Ir·Gd2 uptake in live HeLa cells. Cells were incubated with Ir·Ln2 at
100 μM in full media for 18 h, followed by washing and ﬁxation. Imaging parameters (optimized for Ir·Eu2 at 100 μM) remained constant for both
compounds. (Right) Ir·Gd2 imaged with optimized parameters for this sample. λex = 405 nm, λem = 500−530 nm. (Scale bar = 20 μm throughout.)
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media, using single-photon PLIM, and in ﬁxed HeLa cells, using
two-photon PLIM.
Solution measurements (in water and cell media) were
recorded by scanning a small area of the bulk solution (inside a
MatTek 35 mm glass-bottomed dish), using a 256 × 256 pixel
array on an inverted Nikon Ti-E microscope with single photon
PLIM imaging capabilities. The entire (homogeneous) 256 ×
256 pixel array was analyzed as a single region of interest (ROI)
for each oxygen concentration. Superimposed decay traces
(Figure S20 in the Supporting Information) clearly show the
change in Ir·Gd emission lifetime with the changing
concentration of O2. For both solutions, decay curves were
best ﬁt to a double exponential model; the major lifetime
component (τ1) matches those recorded in a conventional
spectroscopy cuvette, using a lifetime spectrometer.
Lifetime mapping of ﬁxed HeLa cells labeled with Ir·Gd,
using two-photon PLIM, reveals a distribution of lifetimes
across a single cell under air-equilibrated conditions. The higher
intensity emission emanating from the punctate staining of the
cell lysosomes exhibits a shorter emission lifetime, compared to
that of the more-diﬀuse cytoplasmic staining (Figures 8 and 9).
Figure 8 highlights the two diﬀerent staining patterns as ROI-1
(cytoplasm) and ROI-2 (lysosomes) on a typical two-photon
PLIM intensity-based image (where all emitted photons are
binned into one channel). Overlaid decay traces (Figure 8c)
and distribution histograms (Figure 8a, depicting the
distribution of the major component τ1, after ﬁtting all pixels
to a double exponential model) from each ROI (see Figure 8b)
shows the diﬀerence in emission lifetime between cellular
locations: for ROI 1, τ1 = ca. 620 ns; for ROI 2, τ1 = ca. 500 ns.
This variation in lifetime is tentatively attributed to the diﬀerent
local environments experienced by the complex, i.e., acidic cell
lysosomes, in comparison to diﬀuse cytoplasm, rather than
concentration of Ir·Gd within the cell. In solution, the emission
lifetimes of Ir·Gd remain constant with concentration across ca.
2 orders of magnitude (1.0 × 10−6 M to 1.0 × 10−4 M, Figure
S22 in the Supporting Information). Lifetimes recorded in
aqueous solution have a larger percentage contribution from
the shorter lifetime component (τ2 ≈ 60%), in comparison to
CH2Cl2 solutions (τ2 > 10%); however, this contribution
decreases to ca. 40% with increasing concentration. The cellular
environment is more complex than that of a homogeneous
solution and the local concentration of Ir·Gd within the
lysosomes may be higher than that measured in solution.
Therefore, it is possible that aggregation and self-quenching (as
is observed in solution for these types of complex)3b,d,14 also
plays a part in the shorter emission lifetime observed at the
lysosomes.
Having established the range of luminescence lifetimes
within a cell under air, we then repeated the experiment under
diﬀerent concentrations of O2. Two-photon PLIM imaging of
Ir·Gd in ﬁxed HeLa cells across a range of O2 concentrations
(Figure 9) shows that (i) the Ir(III)-based emission lifetime is
sensitive to changing levels of O2, even when ﬁxed inside a
complex cell environment, and (ii) the distribution of lifetimes
across a single cell is maintained. Four lifetime maps are shown
in Figure 9, plotted on the same color scale with the variation
from red to blue as the lifetime varies across the range of 0−
1000 ns. Within Figure 9, the τ1 distribution plots change
visually from principally orange to principally blue, showing
how the luminescence lifetime increases as the O2 concen-
tration decreases. The range of τ1 values within each image are
also plotted as histograms (below) on the same scale, depicting
the change in average luminescence lifetime in a cell with
decreasing levels of O2: average lifetime values of 435, 520, 586,
and 644 ns are obtained with relative O2 concentrations of
100%, 50%, 21%, and 0%, respectively. The response of speciﬁc
Figure 7. Emission spectra recorded from live HeLa cells after
incubation with (left) dinuclear Ir·Ln complexes and (right) trinuclear
Ir·Ln2 complexes.
Figure 8. Lifetime distribution of Ir·Gd across a single HeLa cell: (a)
histogram showing distribution of τ1 values from ROI-1 (cytoplasm)
and ROI-2 (punctate staining), (b) intensity images of ﬁxed HeLa cells
stained with Ir·Gd (50 μM, 18 h) in air, and (c) decay traces
corresponding to ROI 1 (black) and 2 (red). (Scale bar = 10 μm.)
Figure 9. Two-photon PLIM (λex = 760 nm) imaging of Ir·Gd stained
HeLa cells (50 μm, 18 h, ﬁxed) under varying concentrations of O2.
Scale bar = 10 μm.
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lysosomal and cytoplasmic ROI values with changing O2 levels
are shown in Figure 10.
The sensitivity of Ir·Gd luminescence lifetime to changing
levels of oxygen across the three conditions (ﬁxed cells, water,
and full cell media) was quantiﬁed using the Stern−Volmer
equation (eq 2).
τ
τ
= + ·K1 [O ]0 SV 2 (2)
Quenching constants (Ksv) determined from a straight line plot
of [O2] (μM) against τ0/τ, Figure 10 (where τ0 is the emission
lifetime at 100% N2), were very similar for ﬁxed HeLa cells and
water (3.54 × 10−4 μM−1 and 3.80 × 10−4 μM−1, respectively)
but slightly lower for full cell media (2.02 × 10−4 μM−1), which
indicates some environment-dependent sensitivity of the
luminescence toward O2.
Luminescence lifetime values in full media were observed to
be slightly longer than those obtained from aqueous solution or
in ﬁxed cells. We believe the longer observed lifetimeand
lower sensitivity toward quenching by O2in full Modiﬁed
Eagle’s Medium (MEM) cell media is due to the dyad being in
a more protected environment when a large protein such as
fetal calf serum is present in the bulk solution. Binding to large
protein molecules is known to protect small molecules from
collisional quenching with dissolved oxygen; protein titrations
with a luminescent Ru(II) complex have shown that emission
intensity and lifetime increases as the concentration of protein
increases.29 Although proteins and subcellular structures also
exist in ﬁxed cells, the region of interest (in this case, the entire
cell) is nonhomogenous; meaning the lifetime observed from a
single cell is a summative average of the emission properties of
Ir·Gd from multipule cellular environments (potentially at
diﬀerent concentrations). The more homogeneous nature of
MEM in cell media solution provides a more uniformly
protected environment for Ir·Gd, which, when compared to an
entire cell, exhibits a longer lifetime.
For a complex to be a suitable biological O2 sensor, a
signiﬁcant diﬀerence in emission lifetime is required across
physiological concentrations of O2, typically 1%−11%.
30
Platinum and palladium porphyrin-based systems, which have
received much attention as oxygen sensors in recent years,
typically show a 2-fold reduction in emission lifetime (τair =
60−70 μs) as the proportion of O2 increases from 0 to
21%.7e,10b−d Although the O2 sensitivity of Ir·Gd is lower than
such porphyrin systems, this small molecule design does have
some advantages; synthetically, they are less time-consuming
(fewer synthetic steps than large porphyrins), the Gd center
potentially enables this single molecule to act as an MRI probe
in addition to a luminescence-based probe, and the
luminescence lifetime (>10 μs) allows for faster data collection
using point scanning, time-resolved techniques. The fact that a
clear diﬀerence in luminescence lifetime is observed in ﬁxed
HeLa cells with Ir·Gd and changing [O2] is promising for a
dynamic live cell model. Furthermore, modiﬁcation of the
Ir(III) chromophore to elongate the τ0 Ir(III) lifetime (closer
to ca. 5 μs rather than ca. 1 μs) would contribute toward
improved O2 sensitivity, as is observed with other Ir(III)-
containing oxygen sensors.13b,d
■ CONCLUSIONS
In conclusion, dinuclear and trinuclear Ir·Ln and Ir·Ln2
complexes, in which a phosphorescent Ir(III)-based unit is
connected to one or two water-stable lanthanide/amino-
carboxylate units via a rigid, conjugated bridging connection,
have been prepared. The dinuclear complexes performed better
than their trinuclear counterparts for luminescence cell imaging
and also in terms of relaxivity (for Gd complexes). For dual
(luminescence + MRI) imaging applications, the complex Ir·Gd
is a promising candidate. With excellent luminescence imaging
capabilities and low toxicity, it also displays unusually high
relaxivity for a small molecule containing just one Gd(III)
center. Variations in luminescence lifetime allow it to be used as
a sensor toward molecular oxygen, an important biological
analyte, in solution and in vitro. However, to be considered an
ideal in vivo sensor for O2, a more signiﬁcant change in the
phosphorescence lifetime across physiological O2 concentra-
tions would be required: achieving this in future generations is
well within the scope of well-understood synthetic modiﬁca-
tions to the Ir(III)-complex core. Thus, this complex provides
an excellent platform to optimize a dual-imaging oxygen-
sensitive probe.
■ EXPERIMENTAL SECTION
Syntheses. Compound C. The mechanism used to form ligand C
is shown in Scheme 1. Precursors A (1.48 g, 2.2 mmol) and B (0.228
g, 1.0 mmol) (see Scheme 1) were dissolved in anhydrous DMF (20
cm3) under argon. Pd(PPh3)4 (92 mg, 0.08 mmol) and CuI (67 mg,
0.35 mmol) were placed in a separate 100 cm3 Schlenk tube, which
was evacuated and backﬁlled with argon several times. The solution of
A and B was transferred into this reaction vessel via a clean and dry
cannula. Finally, anhydrous triethylamine (5 cm3) was added to the
reaction mixture, which was kept at 80 °C for 3 days with constant
stirring. After removal of the solvent under reduced pressure, the deep
brown residue was dissolved in dichloromethane (DCM, 150 cm3),
then washed with aqueous potassium cyanide (2%, 70 cm3) and with
water (2 × 200 cm3). The organic layer was dried over MgSO4 and
puriﬁed by column chromatography on alumina, eluting initially with
CH2Cl2 and then with 1% MeOH in CH2Cl2, to furnish C as an
orange semisolid (1.16 g, 82%). Caution: Potassium cyanide (KCN) is
highly toxic; it can prevent cellular respiration and should be handled
Figure 10. (Top) Stern−Volmer plots of Ir·Gd under diﬀerent oxygen
concentrations in ﬁxed HeLa cells (red, Ksv = 3.54 × 10
−4 μM−1, τ1 cell
average); full cell media (green, Ksv = 2.02 × 10
−4 μM−1); and water
(black, Ksv = 3.80 × 10
−4 μM−1). (Bottom) Histogram showing Ir·Gd
lifetime variation across ﬁxed cell. Diﬀuse cytoplasmic lifetimes (gray)
are consistently longer than punctate staining (blue) under varying
concentrations of oxygen.
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with care. Extra training may be required by the user. 1H NMR (500
MHz, CDCl3, 298 K, TMS): δ 1.49 (s, 72H), 3.55 (s, 16H), 4.10 (s,
8H), 7.53, (bs, 4H), 7.76 (bs, 2H), 7.92 (bs, 2H), 8.45 (bs, 2H). 13C
NMR (125 MHz, CDCl3, 298 K, TMS): δ = 28.2, 56.1, 59.5, 81.3,
92.0, 122.9, 127.2, 128.5, 129.7, 131.9, 132.2, 133.0, 133.4, 133.8,
138.5, 152.2, 160.1, 170.3. ESI-MS: m/z 1411.8 [20%, (M + H)+];
706.4 [100%, (M + 2H)2+].
[Ir(dfppy)2(C)]PF6 (Complex D). A suspension of C (0.706 g, 0.5
mmol) and [{Ir(dfppy)2Cl}2] (0.304 g, 0.25 mmol) in dry CH2Cl2/
MeOH (50 cm3, 4:1 v/v) was kept at reﬂux for 16 h under an inert
atmosphere. After cooling the reaction mixture to RT, ca. 15 equiv of
NH4PF6 (1.22 g, 7.5 mmol) was added to the reaction mixture with
stirring. After 6 h, the reaction mixture was evaporated near to dryness
and 5 cm3 of CH2Cl2 was added to the residue to completely dissolve
the organic substances. Residual NH4PF6 was ﬁltered oﬀ and the dark
solution was concentrated. The crude product was puriﬁed by column
chromatography on alumina, eluting initially with CH2Cl2 and then
with 2% MeOH in CH2Cl2, to furnish complex D as a deep yellow
crystalline material (0.724 g, 70%). 1H NMR (400 MHz, CDCl3, 298
K, TMS): δ 1.47 (s, 72H), 3.50 (s, 16H), 4.05 (s, 8H), 5.76 (dd, 1H),
5.78 (dd, 1H), 6.62−6.67 (m, 2H), 7.08−7.10 (m, 2H), 7.25 (s, 1H),
7.41−7.43 (m, 2H), 7.63 (s, 1H), 7.70 (s, 2H), 7.81−7.85 (m, 2H),
8.25−8.33 (m, 4H), 8.37−8.39 (m, 2H), 8.76 (d, 1H), 8.83 (d, 1H).
13C NMR (125 MHz, CDCl3, 298 K, TMS): δ 28.1, 55.9, 59.4, 81.1,
86.8, 95.2, 114.2, 121.7, 122.9, 124.1, 127.6, 129.5, 130.3, 131.6, 139.3,
141.9, 142.3, 145.0, 149.0, 151.6, 152.0, 157.9, 159.4, 160.3, 162.4,
163.9, 164.0, 170.4. ESI-MS: m/z 1984 [3%, (M − PF6)
+], 992 [20%,
(M − PF6 + H)
2+], 662 [100%, (M − PF6 + 2H)
3+] all with correct
isotope patterns and spacings.
Complex E. The Ir(III) complex D (0.532 g, 0.25 mmol) was
dissolved in DCM (20 cm3) and cooled to 0 °C. An excess of cold
triﬂuoroacetic acid (5 cm3) was added to this cold solution dropwise
while stirring under an argon atmosphere. The resulting mixture was
stirred for 16 h at 0 °C, after which solvents and other volatile
substances were removed in vacuo. The residue was triturated with
ether (5 × 25 cm3) and ﬁnally ﬁltered to aﬀord the product as a yellow
mass, which was dried in vacuo overnight. The isolated yield was 0.260
g (62%). 1H NMR (500 MHz, DMSO-d6, 298 K, TMS): δ 3.48 (s,
16H), 3.95 (s, 8H), 5.68 (d, 1H), 5.72 (d, 1H), 6.98−7.09 (m, 4H),
7.28 (s, 1H), 7.51 (s, 1H), 7.59 (s, 2H), 7.70−7.73 (m, 2H), 7.97−
8.00 (m, 2H), 8.28−8.31 (m, 4H), 8.43 (s, 2H), 9.29 (d, 2H), 12.42
(br s, 8H). 13C NMR (125 MHz, CDCl3, 298 K, TMS): δ 54.4, 58.9,
88.3, 93.3, 113.5, 121.1, 121.5, 122.4, 122.9, 123.5, 124.4, 128.0, 128.9,
129.6, 131.1, 139.9, 142.5, 144.6, 150.6, 152.8, 157.9, 159.6, 161.6,
162.6, 163.6, 172.3. ESI-MS: m/z: 1535 [25%, (M − CF3CO2)
+], 1490
[90%, (M − CF3CO2 − HCOOH)]
+
Complexes Ir·Ln2 (Ln = Eu(III), Gd(III); Isolated as Na
+ salts). To a
solution of complex E (0.059 g, 0.035 mmol) in MeOH (5 cm3) was
added the appropriate Ln(OTf)3 (0.045 g, 0.075 mmol). The mixture
was stirred for 30 min, after which 1 M aqueous NaOH was added
slowly to aﬀord a pH of 5. The reaction mixture was then stirred at 50
°C for 2 days. Solvents were then evaporated, and the residue was
dissolved in the minimum amount of MeOH and reprecipitated by the
gradual addition of ether; this reprecipitation was repeated several
times after which the product was dried in vacuo. Isolated yield: ca.
0.05 g (75%); the products were pure by HPLC (see the Supporting
Information). Negative-ion ESI-MS for Ir·Eu2: m/z 1831 (100%, [M
− Na]−). ESI-MS for Ir·Gd2: m/z 1842 (100%, [M − Na]
−). These
molecular ions in ESI-MS showed the correct isotope patterns and
spacings.
Cell Culture and Staining. Culture. HeLa cells were cultured in a
humidiﬁed 37 °C, 5% CO2/95% air (v/v) environment in Modiﬁed
Eagle’s Medium (MEM) supplemented with 10% (v/v) fetal calf
serum (FCS), 1% penicillin-streptomycin and 2 mM L-glutamine. Cells
were cultured as monolayers in T-75 ﬂasks and passaged using trypsin-
EDTA. For confocal and PLIM imaging experiments, cells were seeded
in to 35 mm MatTek glass-bottomed dishes until 60% conﬂuent.
Staining. After removal of growth media, cells were washed with
PBS (phosphate-buﬀered saline, 1 mL/well) before treating with a
solution of the appropriate Ir/Ln complex: 25−100 μM in full MEM
(0.04−0.4% DMSO, 16 h at 37 °C, 1 mL/well). All incubation
solutions were diluted from a 20 mM stock solution of Ir·Ln in
DMSO, with the exception of Ir·Eu2 which was diluted from a 10 mM
stock. After incubation, cells were washed with PBS (3 × 1 mL/well)
to remove excess complex, then imaged in 2−3 mL of Phenol Red-free
MEM media.
Co-staining with Lysotracker Red. After incubating with Ir·Ln,
cells were washed with PBS (3 × 1 mL/well) before the addition of
lysotracker Red (Life Technologies), 50 nM in full MEM media for 30
min at 37 °C, after which cells were washed with PBS and covered
with fresh media before imaging.
Confocal Imaging. Confocal images were recorded using an
inverted Nikon Model Eclipse C2 system that was attached to a Nikon
Model Ti−U system, with 405, 488, and 561 nm coupled lasers, as a
combined laser-hub unit from Omicron (UK). For imaging, a Nikon
100× Apo oil immersion objective (NA 1.49) was used, along with
405 nm excitation for Ir·Ln and Ir·Ln2, and 561 nm excitation for
lysotracker Red. Emission ﬁlters used were 515/30 for Ir·Ln and 590
nm long pass (lp) ﬁlter for lysotracker red.
O2 Dependence on Ir·Gd and Lifetime Imaging. Sample
Preparation. Solutions of Ir·Gd in distilled water and full MEM media
(1 × 10−4 M), diluted from a 20 mM DMSO stock, were placed in
Mat Tek 35 mm glass-bottomed dishes, and the excitation light
focused into the bulk of the solution. For ﬁxed cell samples, HeLa cells
were cultured to 60% conﬂuency in Mat Tek 35 mm glass-bottomed
dishes before incubation with Ir·Gd (50 μM, 16 h at 37 °C). After
washing and ﬁxation, cells were covered with PBS for imaging.
Gas Mixtures of O2 and N2. Gas mixtures of O2 and N2 with a ﬂow
rate of 100 mL/min were controlled using Mass View ﬂow meters
(Model MV-302, Bronkhorst). Samples were equilibrated for 20 min
(at RT) with each gas mixture, using a bespoke lid (with inlet and
outlet), before PLIM imaging.
Single Photon PLIM Imaging. A single-photon (405 nm)
phosphorescence lifetime imaging unit was used to record emission
lifetimes of Ir·Gd solutions at varying levels of O2. This system
comprised a Becker & Hickl BDL405 SM laser and DCS120 attached
to a Nikon Ti-E inverted microscope.
Two-Photon PLIM Imaging. A multiphoton (760 nm) phosphor-
escence lifetime imaging unit comprised an adapted Becker & Hickl
DCS120 confocal scanning system and Coherent Mira 900F laser
pumped by a Verdi V10, connected to a Nikon Ti-E inverted
microscope, was used to image ﬁxed cells stained with Ir·Gd under
varying levels of O2.
A water immersion 60× (NA 1.2) objective was used for all samples.
Emission light was collected from 485 nm to 650 nm, using
appropriate ﬁlters.
PLIM Data Collection and Processing. A PLIM imaging window of
24 μs was used for all samples. Regions of interest (entire ﬁeld of view
for solutions, individual cells for ﬁxed cell samples) were analyzed in
SPCImage (Becker & Hickl software, version 5.0) and in Origin
(version 6.0). In all cases, the data were most appropriately ﬁtted to a
double exponential decay model. Reported lifetimes and lifetime maps
depict the major emission component τ1.
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Vinogradov, S. A.; Scadden, D. T.; Lin, C. P. Nature 2014, 508, 269−
273. (d) Jenkins, J.; Dmitriev, R. I.; Morten, K.; McDermott, K. W.;
Papkovsky, D. B. Acta Biomater. 2015, 16, 126−135. (e) Kurokawa,
H.; Ito, H.; Inoue, M.; Tabata, K.; Sato, Y.; Yamagata, K.; Kizaka-
Kondoh, S.; Kadonosono, T.; Yano, S.; Inoue, M.; Kamachi, T. Sci.
Rep. 2015, 5, 10657.
(9) (a) Harris, A. L. Nat. Rev. Cancer 2002, 2, 38−47. (b) Murdoch,
C.; Muthana, M.; Lewis, C. E. J. Immunol. 2005, 175, 6257−6263.
(c) Sun, X.; He, G.; Qing, H.; Zhou, W.; Dobie, F.; Cai, F.;
Staufenbiel, M.; Huang, L. E.; Song, W. Proc. Natl. Acad. Sci. U. S. A.
2006, 103, 18727−18732. (d) Simon, M. C. Cell Metab. 2006, 3, 150−
151. (e) Papandreou, I.; Cairns, R. A.; Fontana, L.; Lim, A. L.; Denko,
N. C. Cell Metab. 2006, 3, 187−197. (f) Taylor, C. T. Biochem. J. 2008,
409, 19−26. (g) Bertout, J. A.; Patel, S. A.; Simon, M. C. Nat. Rev.
Cancer 2008, 8, 967−975.
(10) (a) Finikova, O. S.; Lebedev, A. Y.; Aprelev, A.; Troxler, T.;
Gao, F.; Garnacho, C.; Muro, S.; Hochstrasser, R. M.; Vinogradov, S.
A. ChemPhysChem 2008, 9, 1673−1679. (b) Dmitriev, R. I.; Zhdanov,
A. V.; Ponomarev, G. V.; Yashunski, D. V.; Papkovsky, D. B. Anal.
Biochem. 2010, 398, 24−33. (c) Dmitriev, R. I.; Zhdanov, A. V.;
Jasionek, G.; Papkovsky, D. B. Anal. Chem. 2012, 84, 2930−2938.
(d) Dmitriev, R. I.; Zhdanov, A. V.; Nolan, Y. M.; Papkovsky, D. B.
Biomaterials 2013, 34, 9307−9317. (e) Tsytsarev, V.; Arakawa, H.;
Borisov, S.; Pumbo, E.; Erzurumlu, R. S.; Papkovsky, D. B. J. Neurosci.
Methods 2013, 216, 146−151. (f) Kelly, C. A.; Toncelli, C.; Kerry, J.
P.; Papkovsky, D. B. Sens. Actuators, B 2014, 203, 935−940.
(11) (a) Wilson, D. F.; Vinogradov, S. A.; Grosul, P.; Vaccarezza, M.
N.; Kuroki, A.; Bennett, J. Appl. Opt. 2005, 44, 5239−5248.
(b) Lemon, C. M.; Karnas, E.; Bawendi, M. G.; Nocera, D. G. Inorg.
Chem. 2013, 52, 10394−10406.
(12) (a) Sud, D.; Mehta, G.; Mehta, K.; Linderman, J.; Takayama, S.;
Mycek, M.-A. J. Biomed. Opt. 2006, 11, 050504. (b) Sud, D.; Mycek,
M.-A. J. Biomed. Opt. 2009, 14, 020506. (c) Choi, N. W.; Verbridge, S.
S.; Williams, R. M.; Chen, J.; Kim, J.-Y.; Schmehl, R.; Farnum, C. E.;
Zipfel, W. R.; Fischbach, C.; Stroock, A. D. Biomaterials 2012, 33,
2710−2722. (d) Howard, S. S.; Straub, A.; Horton, N. G.; Kobat, D.;
Xu, C. Nat. Photonics 2012, 7, 33−37. (e) Khan, A. A.; Fullerton-
Shirey, S. K.; Howard, S. S. RSC Adv. 2015, 5, 291−300. (f) Zhang, P.;
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.6b00702
Inorg. Chem. XXXX, XXX, XXX−XXX
J
Huang, H.; Chen, Y.; Wang, J.; Ji, L.; Chao, H. Biomaterials 2015, 53,
522−531.
(13) (a) Yoshihara, T.; Yamaguchi, Y.; Hosaka, M.; Takeuchi, T.;
Tobita, S. Angew. Chem., Int. Ed. 2012, 51, 4148−4151. (b) Lv, W.;
Yang, T.; Yu, Q.; Zhao, Q.; Zhang, K. Y.; Liang, H.; Liu, S.; Li, F.;
Huang, W. Adv. Sci. 2015, 2, 1500107. (c) Zheng, X.; Tang, H.; Xie,
C.; Zhang, J.; Wu, W.; Jiang, X. Angew. Chem., Int. Ed. 2015, 54, 8094−
8099. (d) Yoshihara, T.; Murayama, S.; Masuda, T.; Kikuchi, T.;
Yoshida, K.; Hosaka, M.; Tobita, S. J. Photochem. Photobiol., A 2015,
299, 172−182. (e) Zheng, X.; Wang, X.; Mao, H.; Wu, W.; Liu, B.;
Jiang, X. Nat. Commun. 2015, 6, 5834.
(14) Jana, A.; Baggaley, E.; Amoroso, A.; Ward, M. D. Chem.
Commun. 2015, 51, 8833−8836.
(15) Lazarides, T.; Sykes, D.; Faulkner, S.; Barbieri, A.; Ward, M. D.
Chem.Eur. J. 2008, 14, 9389−9399.
(16) (a) Costa, J.; Ruloff, R.; Burai, L.; Helm, L.; Merbach, A. E. J.
Am. Chem. Soc. 2005, 127, 5147−5157. (b) Werner, E. J.; Datta, A.;
Jocher, C. J.; Raymond, K. N. Angew. Chem., Int. Ed. 2008, 47, 8568−
8580. (c) Datta, A.; Raymond, K. N. Acc. Chem. Res. 2009, 42, 938−
947 and references therein.10.1021/ar800250h (d) Garimella, P. D.;
Datta, A.; Romanini, D. W.; Raymond, K. N.; Francis, M. B. J. Am.
Chem. Soc. 2011, 133, 14704−14709. (e) Stasiuk, G. J.; Smith, H.;
Wylezinska-Arridge, M.; Tremoleda, J. L.; Trigg, W.; Luthra, S. K.;
Iveson, V. M.; Gavins, F. N. E.; Long, N. J. Chem. Commun. 2013, 49,
564−566. (f) Sour, A.; Jenni, S.; Ortí-Suaŕez, A.; Schmitt, J.; Heitz, V.;
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